FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Fresenius Recalls Stay-Safe Catheter Sets

Fresenius Medical Care recalls its Stay-Safe Catheter Extension Sets and Stay-Safe/Luer Lock Adapters to correct their instructions for use to prevent...

latest-news-card-1
Human Drugs

Cancer Trial Performance Status Eligibility Criteria

FDA publishes a draft guidance on using patient performance status as eligibility criteria for cancer drug trials.

latest-news-card-1
Human Drugs

Laboratory Values Cancer Trial Eligibility Criteria

FDA publishes a draft guidance with recommendations for increasing cancer drug trial participant diversity by selecting appropriate laboratory values ...

latest-news-card-1
Medical Devices

Cardinal Health Monoject Inspection Violations

FDA warns Cardinal Health it is distributing unapproved medical devices that also have a Quality System Regulation violation.

latest-news-card-1
Human Drugs

Dr. Reddys Recalls Sapropterin Dihydrochloride

Dr. Reddys Laboratories recalls six lots of sapropterin dihydrochloride powder for oral solution 100 mg due to decreased potency.

latest-news-card-1
Human Drugs

Pivya Approved for Uncomplicated UTIs

FDA approves Utility Therapeutics Pivya for some uncomplicated urinary tract infections.

latest-news-card-1
Biologics

Priority Review for Jemperli sBLA

FDA accepts for priority review a GSK supplemental BLA for Jemperli (dostarlimab) for combination use with standard-of-care chemotherapy (carboplatin ...

latest-news-card-1
Human Drugs

Boehringer on Improving Informed Consent Guide

Boehringer Ingelheim suggests several modifications to an FDA draft guidance on key information and facilitating understanding in informed consent.

latest-news-card-1
Marketing

Biological Promotion Q&A Guidance

FDA publishes a draft guidance with questions and answers on promotional communications for some prescription biologics.

latest-news-card-1
Human Drugs

State Lack of Fenofibrate CV Benefit: Petition

The educational group Healthy Women petitions FDA to change fenofibrate labeling to state there is no proven cardiovascular benefit to using fenofibra...